Drugs / Shengmai Liquid

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT06980636 Dec 2025 → Oct 2026 expected long COVID-19 Beijing University of Chinese Medicine Recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Shengmai Liquid ClinicalTrials.gov intervention name — accepted as the source's own label NCT06980636 ↗
Modality Traditional medicine (herbal / TCM) “traditional Chinese medicine Shengmaiyin oral liquid” NCT06980636 ↗
Route Oral “taken orally at a dose of 10ml per time, three times a day” NCT06980636 ↗